DHA/EPA (Omega-3) and LA/GLA (Omega-6) as bioactive molecules in neurodegenerative diseases

C Kousparou, M Fyrilla, A Stephanou… - International Journal of …, 2023 - mdpi.com
Neurodegenerative diseases are characterized by neuroinflammation, neuronal depletion
and oxidative stress. They coincide with subtle chronic or flaring inflammation, sometimes …

Molecular diagnostics of neurodegenerative disorders

M Agrawal, A Biswas - Frontiers in molecular biosciences, 2015 - frontiersin.org
Molecular diagnostics provide a powerful method to detect and diagnose various
neurological diseases such as Alzheimer's and Parkinson's disease. The confirmation of …

SPTLC1 variants associated with ALS produce distinct sphingolipid signatures through impaired interaction with ORMDL proteins

MA Lone, MJ Aaltonen, A Zidell… - The Journal of …, 2022 - Am Soc Clin Investig
Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that affects
motor neurons. Mutations in the SPTLC1 subunit of serine palmitoyltransferase (SPT), which …

Current insights on lipid nanocarrier-assisted drug delivery in the treatment of neurodegenerative diseases

MI Teixeira, CM Lopes, MH Amaral, PC Costa - European journal of …, 2020 - Elsevier
The central nervous system (CNS) is vulnerable to pathologic processes that lead to the
development of neurodegenerative disorders like Alzheimer's, Parkinson's and Huntington's …

Riluzole: real-world evidence supports significant extension of median survival times in patients with amyotrophic lateral sclerosis

M Hinchcliffe, A Smith - Degenerative neurological and …, 2017 - Taylor & Francis
Amyotrophic lateral sclerosis (ALS) is the commonest form of motor neuron disease and is a
fatal, degenerative, multisystem disorder affecting upper and/or lower motor neurons in the …

Amyotrophic lateral sclerosis (ALS): Stressed by dysfunctional mitochondria-endoplasmic reticulum contacts (MERCs)

J Chen, A Bassot, F Giuliani, T Simmen - Cells, 2021 - mdpi.com
Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disease for which
there is currently no cure. Progress in the characterization of other neurodegenerative …

Therapeutic potential of astrocyte transplantation

N Hastings, WL Kuan, A Osborne… - Cell …, 2022 - journals.sagepub.com
Cell transplantation is an attractive treatment strategy for a variety of brain disorders, as it
promises to replenish lost functions and rejuvenate the brain. In particular, transplantation of …

ALS blood expression profiling identifies new biomarkers, patient subgroups, and evidence for neutrophilia and hypoxia

WR Swindell, CPS Kruse, EO List, DE Berryman… - Journal of translational …, 2019 - Springer
Background Amyotrophic lateral sclerosis (ALS) is a debilitating disease with few treatment
options. Progress towards new therapies requires validated disease biomarkers, but there is …

The emerging role of 5-hydroxymethylcytosine in neurodegenerative diseases

S Al-Mahdawi, SA Virmouni, MA Pook - Frontiers in neuroscience, 2014 - frontiersin.org
DNA methylation primarily occurs within human cells as a 5-methylcytosine (5mC)
modification of the cytosine bases in CpG dinucleotides. 5mC has proven to be an important …

Inflammasome in ALS Skeletal Muscle: NLRP3 as a Potential Biomarker

L Moreno-García, FJ Miana-Mena… - International Journal of …, 2021 - mdpi.com
Since NLRP3 inflammasome plays a pivotal role in several neurodegenerative disorders,
we hypothesized that levels of inflammasome components could help in diagnosis or …